Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Post Reporter.
Press releases published on March 31, 2025
Explosive Investigative Thriller Bribe, Inc. to Make U.S. Premiere Amid Global Reckoning Over Corruption
GlobeNewswire
·
March 31, 2025
Groundbreaking Documentary to Make Its U.S. Debut in Los Angeles April 3, Followed by New York Screening at IFC Center April 15–16 New York Premiere to Feature Post-Screening Q…
LIXTE Launches New Study to Determine if Certain Pre-Cancerous Cells Found in an Aging Population Can Be Eliminated by LB-100
GlobeNewswire
·
March 31, 2025
Pre-Clinical Study in Collaboration with Netherlands Cancer Institute is in addition to LIXTE’s Ongoing Clinical Trials for Ovarian and Colorectal Cancers PASADENA, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or …
Aprea Therapeutics Announces Dosing of Patient with HPV+ Head and Neck Squamous Cell Carcinoma (HNSCC) in Ongoing ACESOT-1051 Trial
GlobeNewswire
·
March 31, 2025
DOYLESTOWN, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific cancer cell vulnerabilities while …
The Now Corporation (OTC: NWPN) and Green Rain Solar Inc. Partner with Chronical Electric to Bring High-Speed EV Charging and Battery Storage to Rochester, NY
GlobeNewswire
·
March 31, 2025
Key Highlights: Transforming Urban EV Infrastructure with Smart Charging Solutions The Now Corporation (OTC: NWPN) and Green Rain Solar Inc. have partnered with Chronical Electric to launch a high-speed electric vehicle (EV) charging station at 1600 West …
Inozyme Pharma to Participate in the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
March 31, 2025
BOSTON, March 31, 2025 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage biopharmaceutical company developing innovative therapeutics for rare diseases that affect bone health and blood vessel function, …
Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System
GlobeNewswire
·
March 31, 2025
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it has integrated Arabic as …
Mindwell Solutions Group Holdings, A TransGlobal Assets Inc. (OTC: TMSH) Subsidiary, Announces Strategic Acquisition of Manifest Technologies Group Assets to Enhance AI-Powered Financial Solutions
GlobeNewswire
·
March 31, 2025
PORTSMOUTH, N.H., March 31, 2025 (GLOBE NEWSWIRE) -- Mindwell Solutions Group Holdings ("MSGH" or the "Company"), a subsidiary of TransGlobal Assets Inc. (OTC: TMSH) focused on innovative technology solutions, today announced the acquisition of Manifest …
Critical Metals Corp.’s Tanbreez Valued at $3 Billion With IRR of 180% and Significant Additional Upside Potential
GlobeNewswire
·
March 31, 2025
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a leading mining development company, today announced that the Company has released an independent Preliminary Economic Assessment …
Veru to Participate in Fireside Chat at the Jones Healthcare and Technology Innovation Conference
GlobeNewswire
·
March 31, 2025
MIAMI, FL, March 31, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced that Mitchell …
AMD Completes Acquisition of ZT Systems
GlobeNewswire
·
March 31, 2025
SANTA CLARA, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) today announced the completion of its acquisition of ZT Systems, a leading provider of AI and general-purpose compute infrastructure for the world’s largest hyperscale providers. The …
HeartCore Reports 2024 Financial Results
GlobeNewswire
·
March 31, 2025
NEW YORK and TOKYO, March 31, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and consulting services company based in Tokyo, reported financial results for the year ended …
HomesToLife Ltd to Hold Conference Call April 11 at 8:30 a.m. ET to Discuss Financial Results for Fiscal Year Ended December 31, 2024
GlobeNewswire
·
March 31, 2025
Singapore, March 31, 2025 (GLOBE NEWSWIRE) -- HomesToLife Ltd (NASDAQ: HTLM) (“HomesToLife” or the “Company”), the holding company of one of the leading home furniture products retail chains in Singapore, today announced that it plans to issue its …
authID Announces Pricing of Approximately $8,150,000 Million Registered Direct Offering
GlobeNewswire
·
March 31, 2025
DENVER, March 31, 2025 (GLOBE NEWSWIRE) -- authID Inc. (NASDAQ: AUID) (“authID” or the “Company”), a leading provider of biometric identity verification and authentication solutions, today announced it has entered into a definitive agreement with investors …
Enovix Reports Progress on 2025 Smartphone Launch
GlobeNewswire
·
March 31, 2025
FREMONT, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a global high-performance battery company, today announced the completion of its second milestone, triggering a payment for sample battery cells shipped under …
Giftify, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
March 31, 2025
SCHAUMBURG, IL, March 31, 2025 (GLOBE NEWSWIRE) -- Giftify, Inc. (NASDAQ: GIFT) (the "Company"), the owner and operator of CardCash.com and Restaurant.com, and a leader in the incentives and rewards industry, today announced financial and operational …
Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
GlobeNewswire
·
March 31, 2025
Conduit secures a composition of matter patent from the USPTO for its lead asset, AZD1656, a Glucokinase Activator targeting autoimmune disorders, positioning the Company for clinical development and strategic partnerships. NAPLES, Fla. and CAMBRIDGE, …
SS Innovations Achieves Significant Milestones in 2024
GlobeNewswire
·
March 31, 2025
The Company’s award winning SSi Mantra surgical robotic system has completed over 3,500 surgeries and is clinically validated to perform more than 100 different types of surgical procedures The Company Continues to Build a Strong Foundation for Future …
Investview, Inc. (“INVU”) Reports Full Year 2024 Financial Results, Operational Highlights and a Year-End Message from the CEO
GlobeNewswire
·
March 31, 2025
$55.4M in Gross Revenue | $8.3M in Net Cash Provided by Operating Activities | Strong Balance Sheet |Share Repurchase Program and Strategic Expansion- for the year ended December 31, 2024 Haverford, PA, March 31, 2025 (GLOBE NEWSWIRE) -- Investview, Inc. ( …
Data Storage Corporation Reports 2024 Fiscal Year Financial Results and Provides Business Update
GlobeNewswire
·
March 31, 2025
Expanded CloudFirst platform in 2024 with 4 new Tier III data centers (UK …
Safety Shot Provides Business Update from CEO Jarrett Boon
GlobeNewswire
·
March 31, 2025
SCOTTSDALE, Ariz., March 31, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or the “Company”), a wellness and dietary supplement company, today provides a business update from CEO Jarrett Boon. To our valued stakeholders, As we …